Home » Topics » Conferences

Conferences
RSS

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Stromelysin inhibitor Bay-12-9566 enters clinical testing for a second indication

Nov. 17, 1998

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Nov. 16, 1998

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Nov. 16, 1998

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

Nov. 16, 1998

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Nov. 16, 1998

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Nov. 16, 1998

More news from AHA: azimilide prevents atrial fibrillation

Nov. 16, 1998

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

Nov. 16, 1998

Celecoxib studies continue to generate impressive efficacy and safety data

Nov. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...